Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine‐Preventable Diseases During International Travel
ConclusionsOur study showed dramatically lower immunity rates for measles and mumps than those shown by prior national seroprevalence studies. The rates in many of the later birth cohorts born after 1966 were significantly lower than the rates reported as necessary to sustain herd immunity. Given that patients' immunization records are not always available or complete, collecting local seroprevalence data may be necessary to more accurately recommend antibody testing and vaccination during pre‐travel assessments.
Source: Journal of Travel Medicine - Category: Infectious Diseases Authors: Gisela Rosario‐Rosario, Marcelo Gareca, Hope Kincaid, Mark C. Knouse Tags: ORIGINAL ARTICLE Source Type: research
More News: Infectious Diseases | Measles | Measles Vaccine | MMR (Measles,Mumps,Rubella) Vaccine | Mumps | Mumps Vaccine | Rubella | Rubella Vaccine | Study | Vaccines